home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Software Vault: The Diamond Collection
/
The Diamond Collection (Software Vault)(Digital Impact).ISO
/
cdr16
/
med9505a.zip
/
M9550204.TXT
< prev
next >
Wrap
Text File
|
1995-03-04
|
2KB
|
27 lines
Document 0204
DOCN M9550204
TI Successful treatment of postherpetic neuralgia with oral ketamine.
DT 9505
AU Hoffmann V; Coppejans H; Vercauteren M; Adriaensen H; Department of
Anesthesia, University Hospital of Antwerpen,; Edegem, Belgium.
SO Clin J Pain. 1994 Sep;10(3):240-2. Unique Identifier : AIDSLINE
MED/95135041
AB OBJECTIVE: To demonstrate the possibilities of the use of oral ketamine
in the treatment of postherpetic neuralgia. SETTING: A pain clinic in a
university hospital. PATIENT: A patient with postherpetic neuralgia of
the ophthalmic nerve. INTERVENTION: Subcutaneous and later oral ketamine
after classical treatment had failed. RESULTS: A complete recovery was
accomplished without any sign of side effects. CONCLUSIONS: Oral
ketamine may provide an alternative in the treatment of postherpetic
neuralgia. The possible mechanism of action by its N-methyl-D-aspartate
(NMDA) blocking properties is discussed.
DE Administration, Oral Adult Case Report Herpes Zoster
Ophthalmicus/*COMPLICATIONS Human HIV Infections/COMPLICATIONS
Injections, Subcutaneous Ketamine/ADMINISTRATION & DOSAGE/*THERAPEUTIC
USE Male Neuralgia/*DRUG THERAPY/ETIOLOGY/PATHOLOGY Ophthalmic
Nerve/PATHOLOGY JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).